ID
25654
Descripción
Study ID: 101468/228 Clinical Study ID: 101468/228 Study Title:A two year Phase IIIb randomised, multicenter, double-blind, SINEMET controlled, parallel group, flexible dose study, to assess the effectiveness of controlled release ropinirole add-on therapy to L-dopa at increasing the time to onset of dyskinesia in Parkinson's disease subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00363727 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Dyskinesias; Parkinson Disease; Parkinson's Disease Study part: Non-serious adverse events
Palabras clave
Versiones (4)
- 12/8/17 12/8/17 -
- 12/8/17 12/8/17 -
- 18/8/17 18/8/17 -
- 8/9/17 8/9/17 -
Subido en
8 de septiembre de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Non-serious adverse events GSK study Dyskinesia in Parkinson's disease NCT00363727
Non-serious adverse events GSK study Dyskinesia in Parkinson's disease NCT00363727
Descripción
Non-serious adverse events
Descripción
If Yes, record details below. Note: If this is a Serious Adverse Event (SAE), do not complete this form, go to the SAE section and complete the SAE form.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1518404
Descripción
Diagnosis Only (if known). Otherwise Sign/Symptom
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0441471
Descripción
Start date
Tipo de datos
date
Alias
- UMLS CUI [1]
- C0808070
Descripción
Outcome
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C1705586
Descripción
End Date
Tipo de datos
date
Alias
- UMLS CUI [1]
- C0806020
Descripción
Maximum Intensity
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0518690
- UMLS CUI [1,2]
- C0877248
Descripción
Action Taken
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826626
Descripción
withdrawal
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C2349954
- UMLS CUI [1,2]
- C1519255
Descripción
AE caused by the investigational product
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0085978
- UMLS CUI [1,2]
- C0877248
Similar models
Non-serious adverse events GSK study Dyskinesia in Parkinson's disease NCT00363727
C0678257 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0443172 (UMLS CUI-2)
(Comment:en)
C0178602 (UMLS CUI-2)
(Comment:en)
(Comment:en)
C1519255 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])